| Literature DB >> 24678844 |
Yan-Jang S Huang, John T Nuckols, Kate M Horne, Dana Vanlandingham, Mario Lobigs, Stephen Higgs1.
Abstract
BACKGROUND: The RGD motif in the mosquito-borne flaviviruses envelope protein domain III (EDIII) FG loop was shown to bind negatively charged cellular molecules and mediate virus entry in mammals. However, its importance in virus entry in the mosquito has not yet been defined. The sequences of RGD motifs are conserved in JEV-serocomplex members primarily transmitted by Culex mosquitoes but absent from members of the DENV serocomplex, which utilize Aedes mosquitoes as vectors. Interestingly, the RGD sequence is present in the attenuated 17D strain of yellow fever virus as a result of the T380R mutation in the EDIII of Asibi strain following extensive in vitro passage in mice and chicken embryos and was found to contribute to the more rapid clearance in mice challenged with 17D. However, viral infectivity and dissemination in mosquitoes had not been evaluated for this mutant.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24678844 PMCID: PMC3974419 DOI: 10.1186/1743-422X-11-60
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
infection rates, calculated as number infected whole mosquitoes and bodies/tested
| Defibrinated sheep blood | N.A. | 0/30 | (0.0%) | 0/24 | (0.0%) | 0/35 | (0.0%) |
| 17D | 6.24 | 9/25 | (36.0%) | 8/12 | (66.7%) | 8/32 | (25.0%) |
| 17D/Asibi M-E | 5.77 | 12/29 | (41.4%) | 13/24 | (54.2%) | 21/39 | (53.8%) |
| 17D/Asibi M-E E T380R | 5.85 | 21/23 | (91.3%)† | 10/12 | (83.3%) | 14/16 | (87.5%)† |
| Asibi | 3.99 | 20/33 | (60.6%) | 9/18 | (50.0%) | 21/38 | (52.6%) |
| Asibi E T380R | 4.21 | 32/48 | (66.7%) | 21/36 | (58.3%) | 21/39 | (53.8%) |
†indicates the significant difference by Fisher’s exact test from 17D/Asibi M-E chimera.
dissemination rates calculated as positive secondary tissues/tested
| 17D | 0/3 | (0.0%) | 1/5 | (20.0%) | 0/12 | (0.0%) |
| 17D/Asibi M-E | 2/6 | (33.3%) | 3/8 | (37.5%) | 7/14 | (50.0%) |
| 17D/Asibi M-E E T380R | 3/14 | (21.4%) | 1/6 | (16.7%) | 5/8 | (62.5%) |
| Asibi | 8/17 | (47.1%) | 4/5 | (80.0%) | 9/15 | (60.0%) |
| Asibi E T380R | 15/19 | (79.0%) | 9/14 | (64.3%) | 10/15 | (66.7%) |
Figure 1Titers of whole-mosquito homogenates of at 7, 10 and 14 d.p.i.